Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)

R. Saccardi, H. Putter, DJ. Eikema, MP. Busto, E. McGrath, B. Middelkoop, G. Adams, M. Atlija, FA. Ayuk, H. Baldomero, Y. Beguin, R. de la Cámara, Á. Cedillo, AMS. Balari, C. Chabannon, S. Corbacioglu, H. Dolstra, RF. Duarte, R. Dulery, R. Greco,...

. 2023 ; 58 (6) : 659-666. [pub] 20230309

Language English Country England, Great Britain

Document type Journal Article

E-resources Online Full text

NLK Free Medical Journals from 1997 to 1 year ago
Freely Accessible Science Journals from 1997 to 1 year ago
ProQuest Central from 1997-01-01 to 1 year ago
Open Access Digital Library from 1997-01-01
Health & Medicine (ProQuest) from 1997-01-01 to 1 year ago

From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. Informed by previous experience from Europe, North America and Australasia, the Clinical Outcomes Group (COG) established criteria for patient and Center selection, and a set of key clinical variables within a dedicated statistical model adapted to the capabilities of the EBMT Registry. The first phase of the project was launched in 2019 to test the acceptability of the benchmarking model through assessment of Centers' performance for 1-year data completeness and survival outcomes of autologous and allogeneic HSCT covering 2013-2016. A second phase was delivered in July 2021 covering 2015-2019 and including survival outcomes. Reports of individual Center performance were shared directly with local principal investigators and their responses were assimilated. The experience thus far has supported the feasibility, acceptability and reliability of the system as well as identifying its limitations. We provide a summary of experience and learning so far in this 'work in progress', as well as highlighting future challenges of delivering a modern, robust, data-complete, risk-adapted benchmarking program across new EBMT Registry systems.

Agence de la Biomédecine Saint Denis France

Australasian Bone Marrow Transplant Recipient Registry Darlinghurst NSW Australia

Autoimmune Diseases Working Party EBMT Barcelona Spain

Belgian Transplant Registry Belgian Cancer Registry Brussels Belgium

Blood and Marrow Transplant Unit IRCCS San Raffaele Hospital Milan Italy

BMT unit Paris Cité University French reference center for aplastic anaemia and PNH French rare network for rare immunological and haematological disorders Saint Louis Hospital Paris France

British Society of Blood and Marrow Transplantation and Cellular Therapy Data Registry London United Kingdom

Cellular Therapy and Transfusion Medicine Unit Careggi University Hospital Florence Italy

Centre de Thérapie Cellulaire Institut Paoli Calmettes Comprehensive Cancer Centre Aix Marseille Université School of Medicine and Inserm CBT 1409 Centre d'Investigations Cliniques en Biothérapies Marseille France

Centre for Hematology and Oncology University Hospital Basel Basel Switzerland

Centre Hospitalier Universitaire Bordeaux Service d'Hematologie et Therapie Cellulaire Bordeaux France

CIBMTR Medical College of Wisconsin Milwaukee WI USA

CIC University of Salamanca IBSAL University Hospital of Salamanca Salamanca Spain

Czech registry Prague Czech Republic

Department of Biomedical Data Sciences Leiden University Medical Center Leiden the Netherlands

Department of Cellular Therapy and Allogeneic Stem Cell Transplantation Karolinska University Hospital Division of Hematology Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden

Department of Haematology Sheffield Teaching Hospitals NHS Foundation Trust Sheffield United Kingdom

Department of Haematology St Vincent's Hospital Sydney Sydney NSW Australia

Department of Hematology CHU of Liège and University of Liège Liège Belgium

Department of Paediatric Oncology Haematology and Stem Cell Transplantation University Children's Hospital Regensburg Regensburg Germany

Department of Stem Cell Transplantation University Medical Center Hamburg Hamburg Germany

EBMT Executive Office Barcelona Spain

EBMT Paris Study Office Paris France

EBMT Registry Leiden the Netherlands

EBMT Statistical Unit Leiden Leiden the Netherlands

Edinburgh and SE Scotland Clinical Transfusion Centre Patient Services and the Edinburgh and SE Scotland Clinical Apheresis Unit Edinburgh United Kingdom

Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular Madrid Spain

Hematology and Bone Marrow Transplantation Unit IRCCS San Raffaele Scientific Institute Milano Italy

Hematology Department Institut Català d'Oncologia Hospitalet Barcelona IDIBELL Universitat de Barcelona Barcelona Spain

Hematology Department Vall d'hebron Institut Oncologic Hospital Vall d'hebron Universitat Autònoma de Barcelona Barcelona Spain

Hematology division Basel University Hospital Basel Switzerland

Hospital Universitario Puerta de Hierro Majadahonda Universidad Autónoma de Madrid Madrid Spain

ICCBBA Barcelona Spain

Infectious Diseases Working Party Barcelona Spain

Italian National BMT Registry Bergamo Italy

JACIE EBMT Executive Office Barcelona Spain

Kenyon M Department of Haematology King's College Hospital NHS Foundation Trust London United Kingdom

King's College Hospital NHS Foundation Trust London United Kingdom

Laboratory of Hematology Department of Laboratory Medicine Radboud University Medical Center Nijmegen the Netherlands

School of Clinical Medicine UNSW Medicine and Health Kensington NSW Australia

School of Medicine Sydney University of Notre Dame Australia Sydney WA Australia

Sorbonne Université INSERM UMRs938 Service d'Hématologie Clinique et de Thérapie Cellulaire Hôpital Saint Antoine AP HP Paris France

Sorbonne University Department of Hematology Hôpital Saint Antoine and INSERM UMRs 938 Paris France

Sorbonne University Hôpital Saint Antoine and INSERM UMRs 938 Paris France

University Hospital Southampton NHS London United Kingdom

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011277
003      
CZ-PrNML
005      
20240528143234.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41409-023-01924-6 $2 doi
035    __
$a (PubMed)36894635
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Saccardi, Riccardo $u Cellular Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy. riccardo.saccardi@aouc.unifi.it
245    10
$a Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE) / $c R. Saccardi, H. Putter, DJ. Eikema, MP. Busto, E. McGrath, B. Middelkoop, G. Adams, M. Atlija, FA. Ayuk, H. Baldomero, Y. Beguin, R. de la Cámara, Á. Cedillo, AMS. Balari, C. Chabannon, S. Corbacioglu, H. Dolstra, RF. Duarte, R. Dulery, R. Greco, A. Gusi, N. Hamad, M. Kenyon, N. Kröger, M. Labopin, J. Lee, P. Ljungman, L. Manson, F. Mensil, N. Milpied, M. Mohty, E. Oldani, K. Orchard, J. Passweg, R. Pearce, RP. de Latour, HA. Poirel, T. Rintala, JD. Rizzo, A. Ruggeri, C. Sanchez-Martinez, F. Sanchez-Guijo, I. Sánchez-Ortega, M. Trnková, DV. Ferreiras, L. Wilcox, LC. de Wreede, JA. Snowden
520    9_
$a From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. Informed by previous experience from Europe, North America and Australasia, the Clinical Outcomes Group (COG) established criteria for patient and Center selection, and a set of key clinical variables within a dedicated statistical model adapted to the capabilities of the EBMT Registry. The first phase of the project was launched in 2019 to test the acceptability of the benchmarking model through assessment of Centers' performance for 1-year data completeness and survival outcomes of autologous and allogeneic HSCT covering 2013-2016. A second phase was delivered in July 2021 covering 2015-2019 and including survival outcomes. Reports of individual Center performance were shared directly with local principal investigators and their responses were assimilated. The experience thus far has supported the feasibility, acceptability and reliability of the system as well as identifying its limitations. We provide a summary of experience and learning so far in this 'work in progress', as well as highlighting future challenges of delivering a modern, robust, data-complete, risk-adapted benchmarking program across new EBMT Registry systems.
650    _2
$a lidé $7 D006801
650    12
$a benchmarking $7 D019985
650    _2
$a kostní dřeň $7 D001853
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    12
$a transplantace hematopoetických kmenových buněk $7 D018380
650    _2
$a akreditace $7 D000068
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Putter, Hein $u Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands $1 https://orcid.org/0000000153951422
700    1_
$a Eikema, Dirk-Jan $u EBMT Statistical Unit Leiden, Leiden, the Netherlands
700    1_
$a Busto, María Paula $u EBMT Registry, Leiden, the Netherlands
700    1_
$a McGrath, Eoin $u ICCBBA, Barcelona, Spain $1 https://orcid.org/000000021956037X
700    1_
$a Middelkoop, Bas $u EBMT Registry, Leiden, the Netherlands
700    1_
$a Adams, Gillian $u EBMT Executive Office, Barcelona, Spain
700    1_
$a Atlija, Marina $u EBMT Registry, Leiden, the Netherlands
700    1_
$a Ayuk, Francis Ayuketang $u Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg, Germany
700    1_
$a Baldomero, Helen $u Centre for Hematology and Oncology, University Hospital Basel, Basel, Switzerland $1 https://orcid.org/000000026554483X
700    1_
$a Beguin, Yves $u Department of Hematology, CHU of Liège and University of Liège, Liège, Belgium
700    1_
$a de la Cámara, Rafael $u Infectious Diseases Working Party (IDWP), Barcelona, Spain
700    1_
$a Cedillo, Ángel $u Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular (GETH-TC), Madrid, Spain
700    1_
$a Balari, Anna María Sureda $u Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, IDIBELL, Universitat de Barcelona, Barcelona, Spain
700    1_
$a Chabannon, Christian $u Centre de Thérapie Cellulaire, Institut Paoli-Calmettes Comprehensive Cancer Centre, Aix-Marseille Université School of Medicine & Inserm CBT-1409, Centre d'Investigations Cliniques en Biothérapies, Marseille, France $1 https://orcid.org/0000000237554889
700    1_
$a Corbacioglu, Selim $u Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, University Children's Hospital Regensburg, Regensburg, Germany
700    1_
$a Dolstra, Harry $u Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
700    1_
$a Duarte, Rafael F $u Hospital Universitario Puerta de Hierro Majadahonda, Universidad Autónoma de Madrid, Madrid, Spain
700    1_
$a Dulery, Rémy $u Sorbonne Université, INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France $1 https://orcid.org/0000000250241713
700    1_
$a Greco, Raffaella $u Blood and Marrow Transplant (BMT) Unit, IRCCS San Raffaele Hospital, Milan, Italy $u Autoimmune Diseases Working Party (ADWP), EBMT, Barcelona, Spain
700    1_
$a Gusi, Andreu $u EBMT Executive Office, Barcelona, Spain
700    1_
$a Hamad, Nada $u Department of Haematology, St Vincent's Hospital Sydney, Sydney, NSW, Australia $u School of Clinical Medicine, UNSW Medicine & Health, Kensington, NSW, Australia $u School of Medicine, Sydney, University of Notre Dame Australia, Sydney, WA, Australia $1 https://orcid.org/0000000179291450
700    1_
$a Kenyon, Michelle $u Kenyon, M, Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom
700    1_
$a Kröger, Nicolaus $u Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg, Germany $1 https://orcid.org/0000000151039966
700    1_
$a Labopin, Myriam $u Sorbonne University, Department of Hematology, Hôpital Saint Antoine, and INSERM UMRs 938, Paris, France $u EBMT Paris Study Office, Paris, France
700    1_
$a Lee, Julia $u British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT) Data Registry, London, United Kingdom
700    1_
$a Ljungman, Per $u Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Manson, Lynn $u Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services and the Edinburgh & SE Scotland Clinical Apheresis Unit, Edinburgh, United Kingdom
700    1_
$a Mensil, Florence $u Agence de la Biomédecine, Saint-Denis, France
700    1_
$a Milpied, Noel $u Centre Hospitalier Universitaire (CHU) Bordeaux, Service d'Hematologie et Therapie Cellulaire, Bordeaux, France $1 https://orcid.org/000000025177014X
700    1_
$a Mohty, Mohamad $u Sorbonne University, Hôpital Saint Antoine (AP-HP), and INSERM UMRs 938, Paris, France $1 https://orcid.org/000000027264808X $7 xx0317729
700    1_
$a Oldani, Elena $u Italian National BMT Registry (GITMO), Bergamo, Italy
700    1_
$a Orchard, Kim $u University Hospital Southampton NHS, London, United Kingdom
700    1_
$a Passweg, Jakob $u Hematology division, Basel University Hospital, Basel, Switzerland
700    1_
$a Pearce, Rachel $u British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT) Data Registry, London, United Kingdom
700    1_
$a de Latour, Régis Peffault $u BMT unit Paris Cité University, French reference center for aplastic anaemia and PNH, French rare network for rare immunological and haematological disorders (MaRIH), Severe aplastic anaemia working party of the European blood and marrow transplantation group (SAAWP EBMT) Saint-Louis Hospital, Paris, France
700    1_
$a Poirel, Hélène A $u Belgian Transplant Registry, Belgian Cancer Registry, Brussels, Belgium $1 https://orcid.org/0000000207125127
700    1_
$a Rintala, Tuula $u King's College Hospital NHS Foundation Trust, London, United Kingdom
700    1_
$a Rizzo, J Douglas $u CIBMTR, Medical College of Wisconsin, Milwaukee, WI, USA $1 https://orcid.org/0000000314741152
700    1_
$a Ruggeri, Annalisa $u Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
700    1_
$a Sanchez-Martinez, Carla $u JACIE, EBMT Executive Office, Barcelona, Spain
700    1_
$a Sanchez-Guijo, Fermin $u CIC-University of Salamanca, IBSAL-University Hospital of Salamanca, Salamanca, Spain $1 https://orcid.org/0000000270767739
700    1_
$a Sánchez-Ortega, Isabel $u EBMT Executive Office, Barcelona, Spain
700    1_
$a Trnková, Marie $u Czech registry, Prague, Czech Republic
700    1_
$a Ferreiras, David Valcárcel $u Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular (GETH-TC), Madrid, Spain $u Hematology Department, Vall d'hebron Institut Oncologic (VHIO), Hospital Vall d'hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
700    1_
$a Wilcox, Leonie $u Australasian Bone Marrow Transplant Recipient Registry (ABMTRR), Darlinghurst, NSW, Australia
700    1_
$a de Wreede, Liesbeth C $u Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands $1 https://orcid.org/0000000276679369
700    1_
$a Snowden, John A $u Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom $1 https://orcid.org/0000000168193476
773    0_
$w MED00000834 $t Bone marrow transplantation $x 1476-5365 $g Roč. 58, č. 6 (2023), s. 659-666
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36894635 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20240528143231 $b ABA008
999    __
$a ok $b bmc $g 1963587 $s 1197542
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 58 $c 6 $d 659-666 $e 20230309 $i 1476-5365 $m Bone marrow transplantation $n Bone Marrow Transplant $x MED00000834
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...